title: Pancreatitis in an HIV-infected person on a tenofovir, didanosine and stavudine containing highly active antiretroviral treatment.
authors.forename: Steven
authors.initials: S
authors.lastname: Callens
authors.forename: Caroline
authors.initials: C
authors.lastname: De Schacht
authors.forename: Veerle
authors.initials: V
authors.lastname: Huyst
authors.forename: Robert
authors.initials: R
authors.lastname: Colebunders
mesh_terms: D000225:Adenine / Q000009:adverse effects / Q000031:analogs & derivatives*; D000328:Adult; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D016049:Didanosine / Q000009:adverse effects; D004347:Drug Interactions; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000009:adverse effects; D010195:Pancreatitis / Q000139:chemically induced*; D019438:Ritonavir / Q000009:adverse effects; D018119:Stavudine / Q000009:adverse effects; D000068698:Tenofovir
chemical_list: D063065:Organophosphonates; D009943:Organophosphorus Compounds; D000068698:Tenofovir; D018119:Stavudine; D000225:Adenine; D016049:Didanosine; D019438:Ritonavir